bf/NASDAQ:ONTX_icon.jpeg

COM:ONCONOVA

Onconova Therapeutics, Inc.

  • Stock

Last Close

1.00

02/04 20:00

Market Cap

20.90M

Beta: -

Volume Today

1.25M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
4.75M
-
800K
83.17%
11.46M
1,332%
5.55M
51.59%
787K
85.81%
1.23M
56.04%
2.18M
77.77%
231K
89.42%
226K
2.16%
226K
0%
226B
99,999,900%
cost of revenue
gross profit
4.75M
-
800K
83.17%
11.46M
1,332%
5.55M
51.59%
787K
85.81%
1.23M
56.04%
2.18M
77.77%
231K
89.42%
226K
2.16%
226K
0%
226B
99,999,900%
selling and marketing expenses
general and administrative expenses
16.79M
-
15.12M
9.97%
9.53M
36.95%
9.18M
3.72%
7.41M
19.32%
7.59M
2.44%
8.35M
10.01%
8.33M
0.23%
9.43M
13.20%
8.45M
10.38%
9.09T
107,659,424.09%
selling general and administrative expenses
16.79M
-
15.12M
9.97%
9.53M
36.95%
9.18M
3.72%
7.41M
19.32%
7.59M
2.44%
8.35M
10.01%
8.33M
0.23%
9.43M
13.20%
8.45M
10.38%
9.09T
107,659,424.09%
research and development expenses
50.18M
-
49.42M
1.51%
25.89M
47.61%
20.07M
22.49%
19.12M
4.74%
16.92M
11.48%
15.54M
8.20%
16.90M
8.76%
7.30M
56.82%
11.41M
56.31%
11.43T
100,210,315.57%
other expenses
63K
-
-50K
179.37%
-35K
30%
30K
-
1.15M
3,736.67%
143K
87.58%
48K
66.43%
12K
75%
663K
5,425%
cost and expenses
66.97M
-
64.54M
3.63%
35.43M
45.11%
29.25M
17.44%
26.52M
9.32%
24.51M
7.59%
23.88M
2.56%
25.22M
5.62%
16.72M
33.71%
19.85M
18.72%
20.52T
103,379,741.84%
operating expenses
66.97M
-
64.54M
3.63%
35.43M
45.11%
29.25M
17.44%
26.52M
9.32%
24.51M
7.59%
23.88M
2.56%
25.22M
5.62%
16.72M
33.71%
19.85M
18.72%
20.52T
103,379,741.84%
interest expense
4K
-
2K
50%
ebitda
-62.16M
-
-63.71M
2.50%
-23.82M
62.61%
-27.66M
16.10%
-27.36M
1.06%
-24.88M
9.08%
-21.76M
12.53%
-24.79M
13.89%
-16.82M
32.15%
-19.63M
16.71%
-20.30T
103,418,659.87%
operating income
-62.22M
-
-63.74M
2.45%
-23.97M
62.39%
-23.70M
1.12%
-25.74M
8.58%
-23.28M
9.54%
-21.70M
6.80%
-24.99M
15.18%
-16.50M
34.00%
-19.63M
18.98%
-20.30T
103,418,659.87%
depreciation and amortization
446K
-
434K
2.69%
150K
65.44%
96K
36%
88K
8.33%
55K
37.50%
-63K
214.55%
208K
430.16%
-321K
254.33%
14K
104.36%
total other income expenses net
105K
-
-32K
130.48%
-35K
9.38%
4.05M
11,671.43%
1.66M
59.06%
2.75M
65.74%
206K
92.50%
-160K
177.67%
333K
308.13%
663K
99.10%
1.35T
203,619,809.50%
income before tax
-62.12M
-
-63.78M
2.66%
-24.01M
62.36%
-19.65M
18.14%
-24.08M
22.52%
-20.53M
14.72%
-21.49M
4.67%
-25.15M
17.03%
-16.16M
35.74%
-18.96M
17.33%
-18.95T
99,915,529.61%
income tax expense
435K
-
19K
95.63%
16K
15.79%
14K
12.50%
13K
7.14%
-124K
1,053.85%
10K
108.06%
4K
60%
-335K
8,475%
net income
-62.54M
-
-63.68M
1.82%
-23.98M
62.35%
-19.67M
17.98%
-24.09M
22.50%
-20.57M
14.61%
-21.50M
4.52%
-25.16M
16.99%
-15.83M
37.08%
-18.30M
15.62%
-18.95T
103,535,225.94%
weighted average shs out
4.71K
-
9.62K
104.40%
10.11K
5.02%
19.67K
94.68%
40.00K
103.32%
274.94K
587.33%
958.97K
248.79%
11.60M
1,109.88%
16.83M
45.08%
20.91M
24.22%
20.99T
100,385,527.96%
weighted average shs out dil
4.71K
-
9.62K
104.40%
10.11K
5.02%
19.67K
94.68%
40.00K
103.32%
274.94K
587.33%
958.97K
248.79%
11.60M
1,109.88%
16.83M
45.08%
20.91M
24.22%
20.99T
100,385,527.96%
eps
-13.28K
-
-6.62K
50.18%
-2.37K
64.15%
-999.64
57.87%
-602.28
39.75%
-74.83
87.58%
-22.42
70.04%
-2.17
90.32%
-0.94
56.68%
-0.88
6.38%
-0.90
2.27%
epsdiluted
-13.28K
-
-6.62K
50.18%
-2.37K
64.15%
-999.64
57.87%
-602.28
39.75%
-74.83
87.58%
-22.42
70.04%
-2.17
90.32%
-0.94
56.68%
-0.88
6.38%
-0.90
2.27%

All numbers in (except ratios and percentages)